Share
Market Research Report

DRUG AND GENE DELIVERY DEVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By ProductSub-retinal Injection Cannula · Extension Tube · Intravenous Catheter · Sterile Insulin Syringe · Pre-filled Syringe · and Infusion Bags
  • By Commercialized DrugsLuxturna · Yescarta · Zolgensma · Kymriah · Provenge · and Strimvelis · By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa
  • Published In26 Mar 2026
  • Report CodeCMI5864
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product
      • Market Snapshot, By Commercialized Drugs
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Rise in burden of chronic diseases across the globe
      • Stringent rules and regulations
      • Increasing demand for drug

         

        and gene delivery devices
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product launch/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4. Global Drug and Gene Delivery Devices Market, By Product, 2021 - 2033, (US$ Thousand)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Sub-retinal Injection Cannula
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
    • Extension Tube
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
    • Intravenous Catheter
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
    • Sterile Insulin Syringe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
    • Pre-filled Syringe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
    • Infusion Bags
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
  5. Global Drug and Gene Delivery Devices Market, By Commercialized Drugs, 2021 - 2033, (US$ Thousand)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Luxturna (Drug Delivery Devices)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
    • Yescarta (Drug Delivery Devices)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
    • Zolgensma (Drug Delivery Devices)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
    • Kymriah (Drug Delivery Devices)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
    • Provenge (Drug Delivery Devices)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
    • Strimvelis (Drug Delivery Devices)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Thousand)
  6. Global Drug and Gene Delivery Devices Market, By Region, 2021 - 2033, (US$ Thousand)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Thousand)
      • Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2021 - 2033,(US$ Thousand)
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Thousand)
      • Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2021 - 2033,(US$ Thousand)
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Thousand)
      • Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2021 - 2033,(US$ Thousand)
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Thousand)
      • Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2021 - 2033,(US$ Thousand)
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Thousand)
      • Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2021 - 2033,(US$ Thousand)
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Thousand)
      • Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2021 - 2033,(US$ Thousand)
  7. Competitive Landscape

    • Pfizer, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Kite Pharma, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bluebird bio, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Vericel Corporation
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • uniQure N.V.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Spark Therapeutics, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Renova Therapeutics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Orchard Therapeutics plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Kolon Tissue Gene, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Human Stem Cell Institute
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Amgen, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Dendreon Pharmaceuticals
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Helixmith Co.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bausch & Lomb Incorporated, Ltd. (ViroMed Co., Ltd.)
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Becton Dickinson and Company
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Castle Creek Biosciences, Inc. (Fibrocell Technologies, Inc.)
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Analyst Views
  8. Section

    • Research Methodology
    • About us